Ripple Software Achieves 96% Clinical Trial Retention
Ripple Software Achieves 96% Clinical Trial Retention Share Article Ripple Science Logo ANN ARBOR, Mich. (PRWEB) May 10, 2021 A white paper recently published by Ripple Science revealed that its flagship product, Ripple, empowered its customers to achieve >96% retention across all trials and 99% retention in 78.2% of completed trials, far outpacing industry averages. Ripple Science is the leading provider of clinical trial softwa...
United Kingdom United States Peter Falzon Johns Hopkins University University Of California Los Angeles Brain Research Foundation Canada
Source: prweb.com